Viagra Medicare Advantage Coverage: What's Actually Covered in 2026

How Medicare Advantage Handles Erectile Dysfunction Drugs

Medicare Advantage plans that include Part D prescription drug benefits (MA-PD plans) set their own formularies within CMS guidelines. Brand-name Viagra is classified by most plans as a non-preferred or excluded brand, which means beneficiaries either pay full price or cannot fill it through the plan at all. Generic sildenafil, by contrast, sits on the formulary of the majority of MA-PD plans, usually on Tier 2 (preferred generic) or Tier 3 (non-preferred generic).

CMS does not mandate coverage of erectile dysfunction medications under Part D. The Medicare Prescription Drug Benefit Manual, Chapter 6 gives plan sponsors discretion to include or exclude drugs used primarily for sexual dysfunction. That discretion is why coverage varies so widely across plans offered by UnitedHealthcare, Humana, Aetna, Cigna, and regional carriers.

A 2019 analysis published in JAMA Internal Medicine found that among Part D plans listing sildenafil, 78% imposed quantity limits and 64% required prior authorization (JAMA Intern Med. 2019;179(11):1584-1586). Those restrictions have remained largely unchanged through 2026 plan year formularies, though the Inflation Reduction Act's $2,000 annual out-of-pocket cap now protects beneficiaries from catastrophic spending on all covered Part D drugs, including sildenafil.

What You'll Actually Pay on a Medicare Advantage Plan

Out-of-pocket cost depends on your plan's tier placement, deductible structure, and whether you have reached the coverage gap. Here is what the numbers look like for a typical MA-PD plan in 2026.

If generic sildenafil is placed on Tier 2 (preferred generic), most plans charge a flat copay between $3 and $15 per fill for up to six tablets. Tier 3 placement pushes the copay to $20 to $45. Plans with a combined medical-drug deductible may require you to pay the full negotiated rate (usually $15 to $50 for six tablets) until the deductible is met.

The $2,000 annual Part D out-of-pocket maximum, which took effect January 1, 2025, means that even beneficiaries who fill multiple prescriptions will not pay more than $2,000 total across all Part D drugs in a calendar year. CMS also introduced a Medicare Prescription Payment Plan that lets enrollees spread Part D costs into monthly installments, reducing the financial shock of filling a prescription in January or February before the deductible is satisfied.

A practical example: a beneficiary on a Humana MA-PD plan with Tier 2 sildenafil, a $0 drug deductible, and a $5 copay would pay $60 per year for 12 fills of six tablets each. That same beneficiary filling brand Viagra at retail without plan coverage would pay roughly $3,600 annually.

Prior Authorization and Quantity Limits: What to Expect

Prior authorization (PA) for sildenafil on MA-PD plans generally requires documentation that the patient has a clinical diagnosis of erectile dysfunction (ICD-10 code N52.x) and has not responded to lifestyle modification alone. Some plans also require confirmation that the patient does not use nitrate medications, a contraindication noted in the FDA-approved prescribing information for sildenafil.

Quantity limits are nearly universal. Six tablets per month is the most common cap, consistent with AUA guidelines recommending on-demand dosing rather than daily use for PDE5 inhibitors in erectile dysfunction. Some plans allow up to 12 tablets when the prescriber documents a clinical rationale.

If your PA is denied, you have the right to file an expedited coverage determination. CMS requires MA plans to respond within 72 hours for standard requests and 24 hours for expedited requests. Winning an appeal often requires a letter of medical necessity from the prescribing clinician that references the AUA guideline recommendation and prior treatment history.

Generic Sildenafil vs. Brand Viagra: The Cost Gap

The price difference is enormous. Brand-name Viagra carries a cash price averaging $50 per tablet at retail pharmacies, according to pricing aggregated from GoodRx and CMS drug pricing tools. Generic sildenafil is available for $2 to $8 per tablet at most chain pharmacies without any insurance.

Pfizer's patent on sildenafil for erectile dysfunction expired in 2020 after its pediatric exclusivity extension ended. Since then, over a dozen generic manufacturers produce sildenafil citrate tablets in 25 mg, 50 mg, and 100 mg strengths. The influx of generic competition drove the average wholesale price down by more than 95% compared to the original brand price.

A study in the Annals of Internal Medicine evaluating price variation across pharmacies found that sildenafil cash prices varied by as much as 800% between the cheapest and most expensive pharmacy within the same ZIP code (Ann Intern Med. 2020;172(8):572-574). The takeaway: shopping across pharmacies matters, especially for Medicare beneficiaries paying out of pocket.

For patients whose MA plan does not cover any sildenafil formulation, cost-plus pharmacies like Mark Cuban Cost Plus Drug Company price generic sildenafil at roughly $0.40 per 20 mg tablet (a dose that can be titrated to the clinician's recommendation). That option sidesteps insurance entirely.

Compounded Sildenafil: A Lower-Cost Alternative

Compounded sildenafil, prepared by 503A or 503B pharmacies, averages approximately $30 for a 30-day supply. Compounded versions are available as sublingual troches, oral suspensions, and rapid-dissolve tablets that some patients prefer over standard oral tablets.

Medicare Part D generally does not cover compounded medications unless the compound contains at least one ingredient that would be covered as a Part D drug. Because sildenafil itself is a Part D-eligible ingredient, some MA-PD plans do cover compounded sildenafil under their formulary, though this is uncommon and typically requires a formal exception request.

The FDA's guidance on compounding emphasizes that 503B outsourcing facilities operate under current good manufacturing practice (CGMP) conditions, while 503A pharmacies compound on a patient-specific prescription basis. Patients considering compounded sildenafil should confirm their pharmacy's registration status on the FDA's Registered Outsourcing Facilities list.

Telehealth platforms, including HealthRX, offer clinician-prescribed compounded sildenafil with transparent pricing that does not depend on insurance coverage. This route eliminates PA delays and quantity-limit restrictions that complicate MA-PD coverage.

Other Ways to Lower the Cost of Sildenafil

Several strategies exist beyond Medicare Advantage formulary coverage.

Pharmacy discount programs. GoodRx, RxSaver, and SingleCare offer coupons that bring generic sildenafil to $4 to $9 for six tablets at participating pharmacies. These programs cannot be combined with Medicare Part D benefits at the point of sale, but they can serve as an alternative when the plan copay exceeds the discount card price.

Pfizer's patient assistance. Pfizer discontinued the brand Viagra direct-to-patient coupon program after generics entered the market, but Pfizer's Pfizer RxPathways program may help qualifying low-income patients access other Pfizer medications. For sildenafil specifically, generic manufacturer patient assistance programs are limited, but NeedyMeds (needymeds.org) maintains an updated database of available programs.

VA pharmacy benefits. Veterans enrolled in VA healthcare can obtain sildenafil through the VA formulary at significantly reduced cost, often $0 to $9 for a 30-day supply, independent of Medicare Advantage enrollment. A retrospective VA pharmacy utilization study found that sildenafil was among the top 20 most dispensed medications across VA medical centers (BMC Health Serv Res. 2021;21:458).

Pill splitting. The 100 mg tablet often costs the same as the 50 mg tablet. Prescribing 100 mg tablets and splitting them in half effectively doubles the supply for the same price. The American Academy of Family Physicians has noted that tablet splitting is appropriate for scored tablets where the active ingredient is evenly distributed, as is the case with sildenafil.

$35 monthly generic programs. Walmart, Costco, and some regional chains include sildenafil on their generic discount lists. Prices start at $4 for six tablets of 20 mg sildenafil (the Revatio strength, sometimes prescribed off-label for ED at higher tablet counts).

How Sildenafil Works and What the Evidence Shows

Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor that blocks the enzyme responsible for breaking down cyclic guanosine monophosphate (cGMP) in the corpus cavernosum. By preserving cGMP levels, sildenafil enhances nitric oxide-mediated vasodilation during sexual stimulation, producing an erection sufficient for intercourse.

The key trial data supporting sildenafil's approval came from a randomized, double-blind, placebo-controlled study published in the New England Journal of Medicine (N=532), which demonstrated that 69% of attempts at intercourse were successful with sildenafil compared with 22% with placebo (P<0.001) (N Engl J Med. 1998;338(20):1397-1404). Onset of action is 30 to 60 minutes, and the effect lasts approximately 4 to 6 hours.

A 2023 systematic review and network meta-analysis in The Lancet compared all four PDE5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil) across 82 RCTs with 47,626 participants. Sildenafil and tadalafil showed similar efficacy for achieving erections sufficient for penetration (OR 3.89 and 3.97, respectively), while tadalafil offered a longer duration of action at 36 hours (Lancet. 2023;402(10409):1209-1222). The choice between agents often comes down to patient preference for on-demand versus daily dosing rather than differences in peak efficacy.

Dr. Arthur Burnett, Professor of Urology at Johns Hopkins and past President of the Sexual Medicine Society of North America, has stated: "PDE5 inhibitors remain the first-line pharmacotherapy for erectile dysfunction. The availability of affordable generics has removed most cost barriers for the majority of patients."

Checking Your Plan's Formulary Before You Enroll

Every October 15 through December 7, during the Medicare Annual Enrollment Period, beneficiaries can switch MA-PD plans. Before choosing a plan, check whether sildenafil is on the formulary and at what tier.

The Medicare Plan Finder at Medicare.gov allows you to search by drug name and ZIP code to compare out-of-pocket costs across available plans. Enter "sildenafil" in the drug search field, specify the dose and quantity, and the tool will display estimated annual costs for each plan.

According to the 2025 Medicare & You handbook published by CMS, beneficiaries who find that their current plan does not cover a needed medication may also qualify for a Special Enrollment Period if they experience a qualifying life event or if the plan makes a mid-year formulary change that affects their coverage.

Dr. Stacie Dusetzina, Professor of Health Policy at Vanderbilt University Medical Center and author of multiple studies on Part D spending, has observed: "The $2,000 out-of-pocket cap fundamentally changes the calculus for beneficiaries who previously avoided filling prescriptions due to cost. For drugs like sildenafil that were often paid entirely out of pocket, this cap provides a meaningful safety net."

When Your MA Plan Says No: Step Therapy and Exceptions

Some MA-PD plans impose step therapy, requiring patients to try a lower-cost ED treatment before approving sildenafil. Step therapy for erectile dysfunction is less common than for conditions like diabetes or hypertension, but it does appear in some restrictive formularies.

If your prescriber believes sildenafil is the appropriate first-line therapy, they can request a formulary exception. CMS requires plans to grant exceptions when the prescriber provides clinical justification that the preferred alternative is either medically inappropriate or has been tried and failed. The exception request process is outlined in 42 CFR §423.578.

Success rates for Part D formulary exception requests are not widely published, but a 2020 CMS audit report found that approximately 72% of standard exception requests were approved at the plan level. For expedited requests involving active prescriptions, the approval rate was higher at 81%.

Keep records of every PA submission and denial letter. If your plan denies coverage at the plan level, you can escalate to an Independent Review Entity (IRE) for a second review. The IRE overturns roughly 40% of first-level denials according to the Medicare Payment Advisory Commission (MedPAC) 2024 Report to Congress.